{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:32:45Z","timestamp":1779363165968,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Noah\u2019s Hope\/Hope 4 Bridget Foundation"},{"name":"NIGMS COBRE","award":["P20GM103548"],"award-info":[{"award-number":["P20GM103548"]}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13311-022-01296-7","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:02:35Z","timestamp":1663081355000},"page":"1905-1919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes"],"prefix":"10.1016","volume":"19","author":[{"given":"Vicki J.","family":"Swier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica C.","family":"Sieren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Knoernschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank A.","family":"Rohret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon J.","family":"Brudvig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2504-4942","authenticated-orcid":false,"given":"Jill M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-022-01296-7_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2660(01)45002-4","article-title":"Neuronal ceroid lipofuscinoses: classification and diagnosis","volume":"45","author":"Wisniewski","year":"2001","journal-title":"Adv Genet"},{"issue":"29","key":"10.1007\/s13311-022-01296-7_bib2","doi-asserted-by":"crossref","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","article-title":"Synergistic effects of treating the spinal cord and brain in CLN1 disease","volume":"114","author":"Shyng","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2004.tb00499.x","article-title":"Current state of clinical and morphological features in human NCL","volume":"14","author":"Goebel","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-022-01296-7_bib4","doi-asserted-by":"crossref","first-page":"754045","DOI":"10.3389\/fneur.2021.754045","article-title":"The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses","volume":"12","author":"Gardner","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1007\/s13311-022-01296-7_bib6","doi-asserted-by":"crossref","first-page":"e0176526","DOI":"10.1371\/journal.pone.0176526","article-title":"A tailored mouse model of CLN2 disease: a nonsense mutant for testing personalized therapies","volume":"12","author":"Geraets","year":"2017","journal-title":"PLoS ONE"},{"issue":"41","key":"10.1007\/s13311-022-01296-7_bib7","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-022-01296-7_bib8","article-title":"Cortical interneuron loss and seizure generation as novel clinically relevant disease phenotypes in Cln2R207X mice","author":"Takahashi","year":"2022","journal-title":"bioRxiv"},{"issue":"6","key":"10.1007\/s13311-022-01296-7_bib9","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1167\/iovs.08-1712","article-title":"Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"49","author":"Katz","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1007\/s13311-022-01296-7_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1007\/s13311-022-01296-7_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gt.2017.4","article-title":"Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression","volume":"24","author":"Katz","year":"2017","journal-title":"Gene Ther"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol Genet Metab"},{"issue":"313","key":"10.1007\/s13311-022-01296-7_bib13","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib14","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1038\/s41598-019-45859-9","article-title":"CRISPR\/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)","volume":"9","author":"Eaton","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1007\/s13311-022-01296-7_bib15","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ymthe.2018.07.015","article-title":"Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 Batten disease","volume":"26","author":"Mitchell","year":"2018","journal-title":"Mol Ther"},{"issue":"10","key":"10.1007\/s13311-022-01296-7_bib16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbadis.2006.09.004","article-title":"A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA","volume":"1762","author":"Tammen","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl A","key":"10.1007\/s13311-022-01296-7_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ejpn.2000.0432","article-title":"Neuronal ceroid lipofuscinosis in Australian Merino sheep: a new animal model","volume":"5","author":"Tammen","year":"2001","journal-title":"Eur J Paediatr Neurol"},{"issue":"10 Pt B","key":"10.1007\/s13311-022-01296-7_bib18","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bbadis.2015.06.013","article-title":"Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network","volume":"1852","author":"Palmer","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"10.1007\/s13311-022-01296-7_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004836117","article-title":"Porcine germline genome engineering","volume":"118","author":"Yang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet Pathol"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"12","key":"10.1007\/s13311-022-01296-7_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120402","article-title":"A porcine model of neurofibromatosis type 1 that mimics the human disease","volume":"3","author":"White","year":"2018","journal-title":"JCI Insight"},{"issue":"22","key":"10.1007\/s13311-022-01296-7_bib23","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1093\/hmg\/ddv356","article-title":"A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease","volume":"24","author":"Beraldi","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib24","doi-asserted-by":"crossref","first-page":"dmm041319","DOI":"10.1242\/dmm.041319","article-title":"Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration","volume":"13","author":"Ardan","year":"2019","journal-title":"Dis Model Mech"},{"issue":"4","key":"10.1007\/s13311-022-01296-7_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11248-009-9245-4","article-title":"Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw","volume":"18","author":"Kragh","year":"2009","journal-title":"Transgenic Res"},{"issue":"5","key":"10.1007\/s13311-022-01296-7_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000088638","article-title":"Postnatal changes in functional activities of the pig's brain: a combined functional magnetic resonance imaging and immunohistochemical study","volume":"14","author":"Fang","year":"2005","journal-title":"Neurosignals"},{"key":"10.1007\/s13311-022-01296-7_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneumeth.2017.11.008","article-title":"Automatic delineation of brain regions on MRI and PET images from the pig","volume":"294","author":"Villadsen","year":"2018","journal-title":"J Neurosci Methods"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib28","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/s41598-020-61251-4","article-title":"Longitudinal phenotype development in a minipig model of neurofibromatosis type 1","volume":"10","author":"Uthoff","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1007\/s13311-022-01296-7_bib29","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1172\/JCI75447","article-title":"Development and translational imaging of a TP53 porcine tumorigenesis model","volume":"124","author":"Sieren","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0192623315622303","article-title":"Computed tomography and magnetic resonance imaging for longitudinal characterization of lung structure changes in a Yucatan miniature pig silicosis model","volume":"44","author":"Hammond","year":"2016","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.vascn.2010.05.005","article-title":"Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products","volume":"62","author":"van der Laan","year":"2010","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1007\/s13311-022-01296-7_bib32","unstructured":"Brudvig JJ, Swier VJ, Johnson TB, et al. Glycerophosphoinositol is elevated in blood samples from CLN3\u0394ex7\u20138 pigs, Cln3\u0394ex7\u20138 mice, and human patients with CLN3 disease. in prep."},{"issue":"5897","key":"10.1007\/s13311-022-01296-7_bib33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.1163600","article-title":"Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs","volume":"321","author":"Rogers","year":"2008","journal-title":"Science"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpn.2012.10.011","article-title":"Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience","volume":"17","author":"Nielsen","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10545-011-9421-6","article-title":"Females experience a more severe disease course in Batten disease","volume":"35","author":"Cialone","year":"2012","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"10.1007\/s13311-022-01296-7_bib36","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/j.pain.0000000000001648","article-title":"Assessment of nociception and related quality-of-life measures in a porcine model of neurofibromatosis type 1","volume":"160","author":"Khanna","year":"2019","journal-title":"Pain"},{"key":"10.1007\/s13311-022-01296-7_bib37","author":"Knoernschild","year":"2022","journal-title":"Magnetic resonance brain volumetry biomarkers of Batten disease identified with minipig model in prep for submission to American Journal of Neuroradiology."},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-022-01296-7_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nbd.2017.08.017","article-title":"Canine neuronal ceroid lipofuscinoses: promising models for preclinical testing of therapeutic interventions","volume":"108","author":"Katz","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"10","key":"10.1007\/s13311-022-01296-7_bib40","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol Ther"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol Ther"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1007\/s13311-022-01296-7_bib43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"Sleat","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib45","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41598-017-01747-8","article-title":"Characterizing microglia activation: a spatial statistics approach to maximize information extraction","volume":"7","author":"Davis","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-022-01296-7_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2021.09.004","article-title":"Gait phenotype in Batten disease: a marker of disease progression","volume":"35","author":"Ostergaard","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"issue":"9","key":"10.1007\/s13311-022-01296-7_bib47","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41433-021-01594-y","article-title":"An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy","volume":"35","author":"Thompson","year":"2021","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1007\/s13311-022-01296-7_bib48","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/humu.23860","article-title":"Mutation update: review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease","volume":"40","author":"Gardner","year":"2019","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-019-0994-8","article-title":"Tracking sex-dependent differences in a mouse model of CLN6-Batten disease","volume":"14","author":"Poppens","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.6.2.4","article-title":"Progression of Pro23His retinopathy in a miniature swine model of retinitis pigmentosa","volume":"6","author":"Scott","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1007\/s13311-022-01296-7_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1001856911730","article-title":"Time courses for maturation of electroretinogram responses from infancy to adulthood","volume":"96","author":"Westall","year":"1998","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib52","first-page":"392","article-title":"The effect of age on human cone and rod ganzfeld electroretinograms","volume":"20","author":"Weleber","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 3b","key":"10.1007\/s13311-022-01296-7_bib53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/eye.1998.148","article-title":"The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses","volume":"12","author":"Weleber","year":"1998","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1007\/s13311-022-01296-7_bib54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1601-183X.2011.00718.x","article-title":"A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis","volume":"10","author":"Sanders","year":"2011","journal-title":"Genes Brain Behav"},{"key":"10.1007\/s13311-022-01296-7_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.exer.2013.10.006","article-title":"Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"116","author":"Whiting","year":"2013","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1007\/s13311-022-01296-7_bib56","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/eye.2016.107","article-title":"Variation in rod and cone density from the fovea to the mid-periphery in healthy human retinas using adaptive optics scanning laser ophthalmoscopy","volume":"30","author":"Wells-Gray","year":"2016","journal-title":"Eye"},{"issue":"3","key":"10.1007\/s13311-022-01296-7_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1463-5224.1999.00077.x","article-title":"Photoreceptor density of the domestic pig retina","volume":"2","author":"Chandler","year":"1999","journal-title":"Vet Ophthalmol"},{"key":"10.1007\/s13311-022-01296-7_bib58","first-page":"2518","article-title":"Topographical characterization of cone photoreceptors and the area centralis of the canine retina","volume":"14","author":"Mowat","year":"2008","journal-title":"Mol Vis"},{"issue":"1\u20132","key":"10.1007\/s13311-022-01296-7_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2015.05.021","article-title":"Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs","volume":"356","author":"Di Giacopo","year":"2015","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1007\/s13311-022-01296-7_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1750-3639.2004.tb00077.x","article-title":"Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation","volume":"14","author":"Tyynela","year":"2004","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00401-005-0024-x","article-title":"Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses","volume":"111","author":"Hachiya","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01296-7_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2019.06.015","article-title":"Gene therapy corrects brain and behavioral pathologies in CLN6-Batten disease","author":"Cain","year":"2019","journal-title":"Mol Ther"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymthe.2020.09.033","article-title":"AAV9 Gene therapy increases lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-batten disease","volume":"29","author":"Johnson","year":"2021","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-022-01296-7_bib64","doi-asserted-by":"crossref","first-page":"101789","DOI":"10.1016\/j.pneurobio.2020.101789","article-title":"A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease","volume":"189","author":"Johnson","year":"2020","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"Le","year":"2008","journal-title":"J Stat Softw"},{"issue":"2","key":"10.1007\/s13311-022-01296-7_bib66","doi-asserted-by":"crossref","first-page":"e0228222","DOI":"10.1371\/journal.pone.0228222","article-title":"Validating indicators of CNS disorders in a swine model of neurological disease","volume":"15","author":"Swier","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib67","doi-asserted-by":"crossref","first-page":"10591","DOI":"10.1038\/s41598-020-67478-5","article-title":"A tailored Cln 3(Q352X) mouse model for testing therapeutic interventions in CLN3 Batten disease","volume":"10","author":"Langin","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1007\/s13311-022-01296-7_bib68","doi-asserted-by":"crossref","first-page":"14962","DOI":"10.1038\/s41598-019-51488-z","article-title":"Changes in motor behavior, neuropathology, and gut microbiota of a Batten disease mouse model following administration of acidified drinking water","volume":"9","author":"Johnson","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1007\/s13311-022-01296-7_bib69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01296-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:37:06Z","timestamp":1761806226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1878747923001435"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01296-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01296-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}